Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals – Carrier is organic
Patent
1983-10-03
1989-06-20
Nucker, Christine M.
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
Carrier is organic
436543, 436805, 436811, 436813, 436824, G01N 33544, G01N 33531
Patent
active
048409154
ABSTRACT:
This invention is directed to a novel group of compounds, herein termed Recognins. Recognins are made by treating malignant tumor cells or artificial cancer cells and separating the desired products. The Recognins may be used to prepare their Chemoreciprocals, i.e., by contacting the Recognins or the Recognins on a support with body fluids. These Chemoreciprocals are useful for diagnostic and therapeutic purposes, i.e., for diagnosing and treating cancers. The Chemoreciprocals are substances which react with immunochemical-like specificity with a Recognin in vivo or in vitro, e.g., in a quantitative precipitin test, in Ouchterlony double diffusion or in immunofluorescence.
REFERENCES:
patent: 4196186 (1980-04-01), Bogoch
Brain Research, Inc.
Nucker Christine M.
LandOfFree
Method for diagnosing malignant tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing malignant tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing malignant tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-525295